| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |